Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 13;122(19):e2505345122.
doi: 10.1073/pnas.2505345122. Epub 2025 May 8.

Structural insights into the ubiquitin-independent midnolin-proteasome pathway

Affiliations

Structural insights into the ubiquitin-independent midnolin-proteasome pathway

Nagesh Peddada et al. Proc Natl Acad Sci U S A. .

Abstract

The protein midnolin (MIDN) augments proteasome activity in lymphocytes and dramatically facilitates the survival and proliferation of B-lymphoid malignancies. MIDN binds both to proteasomes and to substrates, but the mode of interaction with the proteasome is unknown, and the mechanism by which MIDN facilitates substrate degradation in a ubiquitin-independent manner is incompletely understood. Here, we present cryoelectron microscopy (cryo-EM) structures of the substrate-engaged, MIDN-bound human proteasome in two conformational states. MIDN induces proteasome conformations similarly to ubiquitinated substrates by using its ubiquitin-like domain to bind to the deubiquitinase RPN11 (PSMD14). By simultaneously binding to RPN1 (PSMD2) with its C-terminal α-helix, MIDN positions its substrate-carrying Catch domain above the proteasome ATPase channel through which substrates are translocated before degradation. Our findings suggest that both ubiquitin-like domain and C-terminal α-helix must bind to the proteasome for MIDN to stimulate proteasome activity.

Keywords: MIDN; RPN1/PSMD2; RPN11/PSMD14; UBL domain; cryo-EM.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement:The authors declare no competing interest.

References

    1. Glickman M. H., Ciechanover A., The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev. 82, 373–428 (2002). - PubMed
    1. Arkinson C., Dong K. C., Gee C. L., Martin A., Mechanisms and regulation of substrate degradation by the 26S proteasome. Nat. Rev. Mol. Cell Biol. 26, 104–122 (2025). - PMC - PubMed
    1. Huang X. L., Luan B., Wu J. P., Shi Y. G., An atomic structure of the human 26S proteasome. Nat. Struct. Mol. Biol. 23, 778–785 (2016). - PubMed
    1. Chen S. B., et al. , Structural basis for dynamic regulation of the human 26S proteasome. Proc. Natl. Acad. Sci. U.S.A. 113, 12991–12996 (2016). - PMC - PubMed
    1. Lander G. C., et al. , Complete subunit architecture of the proteasome regulatory particle. Nature 482, 186–191 (2012). - PMC - PubMed

MeSH terms

LinkOut - more resources